Exact Mass: 467.1115128
Exact Mass Matches: 467.1115128
Found 182 metabolites which its exact mass value is equals to given mass value 467.1115128,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
AG 2034
N-Desmethylrosuvastatin
C21H26FN3O6S (467.15262680000006)
N-Desmethylrosuvastatin is a metabolite of rosuvastatin. Rosuvastatin (marketed by AstraZeneca as Crestor) is a member of the drug class of statins, used to treat high cholesterol and related conditions, and to prevent cardiovascular disease. It was developed by Shionogi. (Wikipedia)
(2s,4s,5r,6r)-5-Acetamido-4-hydroxy-2-(4-methyl-2-oxo-chromen-7-yl)oxy-6-[(2r)-1,2,3-trihydroxypropyl]tetrahydropyran-2-carboxylic acid
C21H25NO11 (467.14275399999997)
(2S)-2-[[5-[2-[(6S)-2-Amino-4-oxo-1,6,7,8-tetrahydropyrimido[5,4-b][1,4]thiazin-6-yl]ethyl]thiophene-2-carbonyl]amino]pentanedioic acid
Bepafant
C23H22ClN5O2S (467.11826620000005)
C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors
FK-614
C21H23Cl2N3O3S (467.08371080000006)
Antibiotic K 252a
C27H21N3O5 (467.14811360000004)
Pelitinib
4-(3-Chloro-2-cyanophenoxy)-N-(4-piperidinophenyl)benzenesulfonamide
C24H22ClN3O3S (467.10703320000005)
k-252a
C27H21N3O5 (467.14811360000004)
A organic heterooctacyclic compound that is a potent inhibitor of protein kinase C and is isolated from Nocardiopsis sp K-252a C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor D004791 - Enzyme Inhibitors K-252a, a staurosporine analog, inhibits protein kinase, with IC50 values of 470 nM, 140 nM, 270 nM, and 1.7 nM for PKC, PKA, Ca2+/calmodulin-dependent kinase type II, and phosphorylase kinase, respectively[1][2]. K-252a is a potent inhibitor (IC50 of 3 nM) of the tyrosine protein kinase (TRK) activity of the NGF receptor gp140trk, the product of the trk protooncogene[3].
Cys Cys Asp Lys
Cys Cys Asp Gln
Cys Cys Glu Asn
Cys Cys Gly Trp
Cys Cys Lys Asp
Cys Cys Asn Glu
Cys Cys Gln Asp
Cys Cys Trp Gly
Cys Asp Cys Lys
Cys Asp Cys Gln
Cys Asp Lys Cys
Cys Asp Gln Cys
Cys Glu Cys Asn
Cys Glu Asn Cys
Cys Gly Cys Trp
Cys Gly Trp Cys
Cys Lys Cys Asp
Cys Lys Asp Cys
Cys Met Asn Thr
Cys Met Gln Ser
Cys Met Ser Gln
Cys Met Thr Asn
Cys Asn Cys Glu
Cys Asn Glu Cys
Cys Asn Met Thr
Cys Asn Thr Met
Cys Gln Cys Asp
Cys Gln Asp Cys
Cys Gln Met Ser
Cys Gln Ser Met
Cys Ser Met Gln
Cys Ser Gln Met
Cys Thr Met Asn
Cys Thr Asn Met
Cys Trp Cys Gly
Cys Trp Gly Cys
Asp Cys Cys Lys
Asp Cys Cys Gln
Asp Cys Lys Cys
Asp Cys Gln Cys
Asp Lys Cys Cys
Asp Gln Cys Cys
Glu Cys Cys Asn
Glu Cys Asn Cys
Glu Asn Cys Cys
Gly Cys Cys Trp
Gly Cys Trp Cys
Gly Trp Cys Cys
Lys Cys Cys Asp
Lys Cys Asp Cys
Lys Asp Cys Cys
Met Cys Asn Thr
Met Cys Gln Ser
Met Cys Ser Gln
Met Cys Thr Asn
Met Asn Cys Thr
Met Asn Thr Cys
Met Gln Cys Ser
Met Gln Ser Cys
Met Ser Cys Gln
Met Ser Gln Cys
Met Thr Cys Asn
Met Thr Asn Cys
Asn Cys Cys Glu
Asn Cys Glu Cys
Asn Cys Met Thr
Asn Cys Thr Met
Asn Glu Cys Cys
Asn Met Cys Thr
Asn Met Thr Cys
Asn Thr Cys Met
Asn Thr Met Cys
Gln Cys Cys Asp
Gln Cys Asp Cys
Gln Cys Met Ser
Gln Cys Ser Met
Gln Asp Cys Cys
Gln Met Cys Ser
Gln Met Ser Cys
Gln Ser Cys Met
Gln Ser Met Cys
Ser Cys Met Gln
Ser Cys Gln Met
Ser Met Cys Gln
Ser Met Gln Cys
Ser Gln Cys Met
Ser Gln Met Cys
Thr Cys Met Asn
Thr Cys Asn Met
Thr Met Cys Asn
Thr Met Asn Cys
Thr Asn Cys Met
Thr Asn Met Cys
Trp Cys Cys Gly
Trp Cys Gly Cys
Trp Gly Cys Cys
N-[4-(4-amino-7-cyclopentylpyrrolo[2,3-d]pyrimidin-5-yl)-2-chlorophenyl]benzenesulfonamide
C23H22ClN5O2S (467.11826620000005)
3-[[4-(2,4,6-trinitroanilino)benzoyl]amino]benzoic acid
C20H13N5O9 (467.07132480000007)
4-Acetamidophenyl-2,3,4-tri-O-acetyl-b-D-glucuronide methyl ester
C21H25NO11 (467.14275399999997)
2 6-DICHLORO-4-(2 4 6-TRIPHENYL-1-PYRI-&
C29H19Cl2NO (467.08436240000003)
disodium,3-[4-[(5-nitropyridin-2-yl)diazenyl]-3-oxido-N-propylanilino]propane-1-sulfonate
(5AS, 10BR)-(-)-5A,10B-DIHYDRO-2-(PENTAFLUOROPHENYL)-4H,6H-INDENO[2,1-B][1,2,4]TRIZOLO[4,3-D][1,4]OXAZINIUM TETRAFLUOROBORATE
dimethyl 2-[[1-(4-chlorobenzoyl)-2-(trifluoromethyl)indol-3-yl]methyl]propanedioate
C22H17ClF3NO5 (467.07472980000006)
2-Pentafluorophenyl-6,10b-dihydro-4H,5aH-5-oxo-3,10c-diaza-2-azoniacyclopenta[c]fluorine tetrafluoroborate
CIQ
C26H26ClNO5 (467.1499416000001)
CIQ is a subunit-selective potentiator of NMDA receptors containing the NR2C or NR2D subunit. IC50 value: 2.7 μM (EC50, for NR2C) and 2.8 μM (EC50, NR2D) Target: NMDA receptor CIQ increases channel opening frequency of recombinant NR2Cor NR2D containing receptors by two-fold (EC50 = 2.7 and 2.8 μM, respectively), with no effect on NR2A or NR2B subtypes. CIQ does not alter the EC50 values for glutamate or glycine on channel opening. CIQ increases channel opening efficiency and enhances NMDA receptor responses. CIQ reduces associated behaviours in schizophrenia models and potentially enhances dopamine release in Parkinson's disease models.
Pelitinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors COVID info from PDB, Protein Data Bank D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(S)-Fmoc-phenylalanine-4-sulfonic acid
C24H21NO7S (467.10386760000006)
1-(2,4-dichlorobenzyl)-2-methyl-N-(pentylsulfonyl)-1H-benzo[d]imidazole-6-carboxamide
C21H23Cl2N3O3S (467.08371080000006)
FK614 is an orally active, non-thiazolidinedione (TZD) type, and selective PPARγ modulator (SPPARM). FK614 functions as a PPARγ agonist with potent anti-diabetic activity in vivo. FK614 has different effects on the activation of PPARγ at each stage of adipocyte differentiation. FK614 can be used for the research of hyperglycemia, hypertriglyceridemia, glucose intolerance and type 2 diabetes[1][2].
1,4-Pentanediamine, N1,N1-bis(2-chloroethyl)-N4-(6-chloro-2-methoxy-9-acridinyl)-
C23H28Cl3N3O (467.12978480000004)
D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes
2-(6-Chloro-3-{[2,2-difluoro-2-(1-oxido-2-pyridinyl)ethyl]amino}-2-oxo-1(2H)-pyrazinyl)-N-[(2-fluorophenyl)methyl]acetamide
N-[4-(4-fluorophenyl)-2-thiazolyl]-2-[(4-methylphenyl)sulfonylamino]benzamide
C23H18FN3O3S2 (467.07735699999995)
N-(4-chlorophenyl)-2-[[4-(4-methoxyphenyl)-5-[(1-methyl-2-pyrrolyl)methyl]-1,2,4-triazol-3-yl]thio]acetamide
C23H22ClN5O2S (467.11826620000005)
N-(1,3-benzodioxol-5-yl)-2-[[6-methyl-4-oxo-3-(phenylmethyl)-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]thio]acetamide
C23H21N3O4S2 (467.09734260000005)
(5s)-5-(2-Amino-2-Oxoethyl)-4-Oxo-N-[(3-Oxo-3,4-Dihydro-2h-1,4-Benzoxazin-6-Yl)methyl]-3,4,5,6,7,8-Hexahydro[1]benzothieno[2,3-D]pyrimidine-2-Carboxamide
C22H21N5O5S (467.12633360000007)
2-[[5-[2-(2-Amino-4-oxo-3,6,7,8-tetrahydropyrimido[5,4-b][1,4]thiazin-6-yl)ethyl]thiophene-2-carbonyl]amino]pentanedioic acid
2-(3-Hydroxymercurio-2-methoxypropylcarbamoyl)phenoxyacetic acid
(Z)-N-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide
Benzyl 2-[3-[3-(furan-2-ylmethylamino)-3-oxopropyl]-2,4-dioxothieno[3,2-d]pyrimidin-1-yl]acetate
C23H21N3O6S (467.11510060000006)
N-Cyclopentyl-4-[4-(furan-2-carbonyl)-piperazine-1-sulfonyl]-benzenesulfonamide
6-Hydroxy-1-(2-methoxyphenyl)-2-[[2-(4-morpholinyl)-2-oxoethyl]thio]-5-(phenylmethyl)-4-pyrimidinone
C24H25N3O5S (467.15148400000004)
2-(4-chloro-3,5-dimethylphenoxy)-N-[4-[4-[2-furanyl(oxo)methyl]-1-piperazinyl]phenyl]acetamide
C25H26ClN3O4 (467.1611746000001)
2-[[5-[[2-(3-Chloroanilino)-4-thiazolyl]methyl]-4-(3-methoxypropyl)-1,2,4-triazol-3-yl]thio]acetic acid methyl ester
C19H22ClN5O3S2 (467.08525320000007)
N-[4-({[(4-tert-butylphenyl)carbonyl]carbamothioyl}amino)-2-methoxyphenyl]thiophene-2-carboxamide
C24H25N3O3S2 (467.13372599999997)
3-Bromo-5-[[4-[hydroxy(diphenyl)methyl]-1-piperidinyl]-oxomethyl]-2-pyranone
C24H22BrNO4 (467.07321120000006)
3-[4-(4-Morpholinylsulfonyl)phenyl]propanoic acid [2-[(5-chloro-2-pyridinyl)amino]-2-oxoethyl] ester
C20H22ClN3O6S (467.0917782000001)
N-(4-fluorophenyl)-2-[[5-(2-fluorophenyl)-1,3,4-oxadiazol-2-yl]thio]-N-[(4-methoxyphenyl)methyl]acetamide
N-[(2S,3R,6R)-6-[2-[(2-chlorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(3-pyridinyl)acetamide
C21H26ClN3O5S (467.1281616000001)
N-[(2S,3S,6S)-6-[2-[(2-chlorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)oxan-3-yl]-2-pyridin-3-ylacetamide
C21H26ClN3O5S (467.1281616000001)
N-[(2R,3R,6R)-6-[2-[(2-chlorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)oxan-3-yl]-2-pyridin-3-ylacetamide
C21H26ClN3O5S (467.1281616000001)
N-[(2S,3S,6R)-6-[2-[(2-chlorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(3-pyridinyl)acetamide
C21H26ClN3O5S (467.1281616000001)
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-7-(3-methoxyphenyl)-6-oxo-1-(2-thiazolylmethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid methyl ester
C24H25N3O5S (467.15148400000004)
N-[(2S,3R,6S)-6-[2-[(2-chlorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(3-pyridinyl)acetamide
C21H26ClN3O5S (467.1281616000001)
N-[(2R,3R,6S)-6-[2-[(2-chlorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(3-pyridinyl)acetamide
C21H26ClN3O5S (467.1281616000001)
N-[2-[(2R,5S,6R)-5-[(2-chlorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-pyridin-4-ylacetamide
C21H26ClN3O5S (467.1281616000001)
N-[2-[(2R,5S,6S)-5-[(2-chlorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-pyridin-4-ylacetamide
C21H26ClN3O5S (467.1281616000001)
N-[(2R,3S,6R)-6-[2-[(2-chlorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(3-pyridinyl)acetamide
C21H26ClN3O5S (467.1281616000001)
N-[(2R,3S,6S)-6-[2-[(2-chlorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(3-pyridinyl)acetamide
C21H26ClN3O5S (467.1281616000001)
N-[2-[(2S,5R,6S)-5-[(2-chlorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-pyridin-4-ylacetamide
C21H26ClN3O5S (467.1281616000001)
N-[2-[(2R,5R,6S)-5-[(2-chlorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-pyridin-4-ylacetamide
C21H26ClN3O5S (467.1281616000001)
N-[2-[(2S,5S,6R)-5-[(2-chlorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-pyridin-4-ylacetamide
C21H26ClN3O5S (467.1281616000001)
N-[2-[(2S,5R,6R)-5-[(2-chlorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]ethyl]-2-pyridin-4-ylacetamide
C21H26ClN3O5S (467.1281616000001)
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-7-(3-methoxyphenyl)-6-oxo-1-(2-thiazolylmethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid methyl ester
C24H25N3O5S (467.15148400000004)
[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 3-hydroxybenzoate
L-Glutamic acid, N-((5-(2-((6S)-2-amino-4,6,7,8-tetrahydro-4-oxo-1H-pyrimido(5,4-b)(1,4)thiazin-6-yl)ethyl)-2-thienyl)carbonyl)-
(2r)-3-({2-ethyl-4,5,9-trihydroxy-10-oxobenzo[b]fluoren-11-yl}sulfanyl)-2-[(1-hydroxyethylidene)amino]propanoic acid
C24H21NO7S (467.10386760000006)
4,4-dichloro-n-{5-chloro-4-methyl-1-oxo-1-[2-(1,3-thiazol-2-yl)pyrrolidin-1-yl]pentan-2-yl}-n,3-dimethylbutanamide
C19H28Cl3N3O2S (467.09677180000006)
12-bromo-6-hydroxy-4-(1h-imidazol-4-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one
methyl (15s,16r,18r)-3,16-dihydroxy-15-methyl-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1¹⁵,¹⁸.0²,⁶.0⁷,²⁷.0⁸,¹³.0¹⁹,²⁶.0²⁰,²⁵]octacosa-1(26),2(6),3,7(27),8(13),9,11,20(25),21,23-decaene-16-carboxylate
C27H21N3O5 (467.14811360000004)
(4e,7s,9r)-12-bromo-6-hydroxy-4-(3h-imidazol-4-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.0²,⁷.0¹⁰,¹⁵]hexadeca-5,10,12,14-tetraen-3-one
methyl 3,16-dihydroxy-15-methyl-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1¹⁵,¹⁸.0²,⁶.0⁷,²⁷.0⁸,¹³.0¹⁹,²⁶.0²⁰,²⁵]octacosa-1(26),2(6),3,7(27),8(13),9,11,20(25),21,23-decaene-16-carboxylate
C27H21N3O5 (467.14811360000004)
methyl (15s,16s,18r)-3,16-dihydroxy-15-methyl-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1¹⁵,¹⁸.0²,⁶.0⁷,²⁷.0⁸,¹³.0¹⁹,²⁶.0²⁰,²⁵]octacosa-1(26),2(6),3,7(27),8(13),9,11,20(25),21,23-decaene-16-carboxylate
C27H21N3O5 (467.14811360000004)